Skip to main content
Oxford Medical Case Reports logoLink to Oxford Medical Case Reports
. 2025 Sep 28;2025(9):omaf176. doi: 10.1093/omcr/omaf176

Adams-Oliver syndrome: an unusual congenital disorder

Leen Jarjanazi 1,, Sarah Kebbeh 2, Eymar Alam 3, Qamar Saado 4, Mulham Jarjanazi 5, Lama Alkadi 6, Aladdin Etr 7, Taoufik Ghazal Aswad 8, Hamdi Nawfal 9
PMCID: PMC12476548  PMID: 41025031

Abstract

Background: Adams-Oliver syndrome (AOS) is a rare congenital disorder characterized by scalp and limb malformations, including scalp aplasia and digital anomalies such as brachydactyly or oligodactyly. While typically inherited through either autosomal dominant or recessive patterns, sporadic cases have also been documented. Case Presentation: A male neonate, born to consanguineous parents, presented with classic features of AOS including aplasia cutis congenita (ACC) and terminal transverse limb defects (TTLD). The mother reported antidepressant use during the first trimester. Prenatal ultrasound findings were suggestive of AOS, which was confirmed postnatally by a large vertex scalp defect with absent skin and bone along with bilateral brachysyndactyly. All biochemical tests were normal, with no evidence of cardiovascular or neurological abnormalities. Conclusions: This case highlights the critical importance of early prenatal diagnosis for severe AOS through meticulous sagittal plane ultrasonography to detect vertex bone ossification defects. Given the poor postnatal prognosis, early recognition is essential to improve outcomes through timely intervention.

Keywords: Adams–Oliver syndrome, aplasia cutis congenita, brachysyndactyly, case report

Background

Adams-Oliver syndrome (AOS) is an uncommon disorder affecting approximately 1 in 225 000 births [1]. First identified by American clinical geneticist Forrest H. Adams and pediatric cardiologist Clarence Paul Oliver in a family with eight affected members [2], AOS presents with characteristic features including aplasia cutis congenita (a skin development abnormality) and limb malformations such as syndactyly, brachydactyly, or oligodactyly [3].

In some cases, incomplete ossification of the skull underlying the affected scalp area may occur, resulting in scarring and permanent alopecia [3]. The lower extremities are typically more severely affected than the upper limbs [4]. Additional manifestations may include cardiovascular anomalies (ventricular septal defects, Tetralogy of Fallot), vascular abnormalities, pulmonary hypertension, cutis marmorata telangiectatica congenita, and less frequently, hepatic, renal, or ocular involvement [1, 4]. Rare neurological findings have been reported, including cerebral cortical dysplasia, corpus callosum hypoplasia, ventricular dysmorphism, periventricular calcifications, and polymicrogyria [5–8].

Six genes have been associated with AOS, demonstrating either autosomal dominant or recessive inheritance patterns [9]. The causative genes include DLL4, ARHGAP31, and NOTCH1 (autosomal dominant) along with EOGT, DOCK6, and RBPJ (autosomal recessive) [9].

Treatment varies according to symptom severity and clinical presentation [10]. Systemic involvement, particularly of internal organs, significantly affects prognosis and may lead to fatal outcomes [11].

Case presentation

An 18-year-old primigravida at full term presented to the Obstetrics and Gynecology Department with labor and fetal distress. An emergency cesarean section (EmCS) was performed, delivering a 2800 g newborn. The mother reported using nortriptyline (50 mg daily) during her first trimester. Prenatal ultrasound had demonstrated absent parietal bone ossification, initially misinterpreted as an imaging artifact. Due to this misinterpretation, a fetal echocardiography was not performed. [Fig. 1]. The mother’s medical history was otherwise unremarkable, though consanguinity was noted (her husband was her cousin). At delivery, the neonate presented with a large (11 × 9 cm) vertex scalp defect involving complete absence of skin and bone, exposing meninges and venous sinuses [Figs 2A,B and 3], along with bilateral lower extremity brachysyndactyly [Figs 4, 5]. Other physical and neurological examinations were normal, as were biochemical tests and abdominal ultrasonography. The neurosurgery and plastic surgery teams were consulted for management. Initial care included daily Fucidin gauze dressings to protect the defect, IV antibiotic therapy, and preparation for skin grafting. However, the lesion developed fibrous exudate with progressive recession. During preoperative preparation, localized infection progressed to bacteremia. The neonate’s condition rapidly deteriorated, culminating in death several days postpartum.

Figure 1.

Figure 1

The figure shows an absence of ossification of the parietal area of the skull which indicates severe aplasia cutis congenita suggesting (AOS) syndrome as a differential diagnosis.

Figure 2.

Figure 2

(A, B) an absence of the bone and the skin overlying the neonate’s scalp vertex which measures 11 × 9 cm. (A) Severe aplasia cutis congenita extending to the bone of the skull. (B) the superior sagittal venous sinus is clearly visible, which is a risk factor that may lead to severe bleeding or infection.

Figure 3.

Figure 3

The appearance of the exposed meninges and dilated blood vessels.

Figure 4.

Figure 4

The figure shows shortening and fusion of the fingers in the bilateral lower limbs.

Figure 5.

Figure 5

More figures showing the shortening and fusion of the fingers in the bilateral lower limbs.

Discussion

Adams-Oliver syndrome (AOS) is a rare disorder characterized by aplasia cutis congenita (ACC) and terminal transverse limb defects (TTLD) [4]. The diagnosis of AOS requires three key criteria: (1) terminal transverse limb abnormalities, (2) ACC, and (3) a positive family history [12]. Additional minor diagnostic features include vascular defects, congenital heart disorders, and cutis marmorata. A diagnosis can be established with either one major and one minor criterion or two major criteria [12].

A hallmark of AOS is its highly variable genotype–phenotype correlation, underscoring the need for a systematic and adaptable multidisciplinary approach in patient evaluation [13].

In our case, the infant presented with severe ACC involving the skull, exposing the meninges, along with TTLD limited to the lower extremities. Although no cardiovascular or neurological abnormalities were detected, the neonate succumbed to a secondary infection within days. Prenatal ultrasound revealed absent parietal skull ossification, a finding that could have supported an earlier AOS diagnosis; however, it was initially dismissed as an artifact.

While ultrasound is not universally reliable for diagnosing AOS—particularly in mild to moderate cases where ACC and TTLD may be subtle—it remains a critical tool in severe cases, such as ours. Early detection is vital, given the poor prognosis associated with severe AOS, and prenatal diagnosis may improve outcomes.

Further diagnostic measures, such as sagittal ultrasound, fetoscopy, or genetic testing (via amniocentesis or chorionic villus sampling), could enhance prenatal detection. Prenatal diagnosis not only provides pathogenic insights but also helps parents understand the severity of the condition.

The exact pathogenesis of AOS remains unclear [14]. Although a genetic component is suspected, our case showed no familial history of similar manifestations, despite consanguinity. This suggests a possible isolated occurrence, though genetic factors cannot be entirely excluded.

While antidepressant use in the first trimester raises concerns, no studies have established a link between antidepressants and AOS. Research indicates a potential association with cardiovascular malformations, but no significant increase in overall congenital malformation risk has been confirmed [15].

Contributor Information

Leen Jarjanazi, Aleppo University Obstetrics and Gynecology Department- Faculty of Medicine, Aleppo, Syria.

Sarah Kebbeh, Aleppo University Obstetrics and Gynecology Department- Faculty of Medicine, Aleppo, Syria.

Eymar Alam, Aleppo University Obstetrics and Gynecology Department- Faculty of Medicine, Aleppo, Syria.

Qamar Saado, Aleppo University Obstetrics and Gynecology Department- Faculty of Medicine, Aleppo, Syria.

Mulham Jarjanazi, Pediatric Surgery Department- Aleppo University Hospital, Aleppo, Syria.

Lama Alkadi, Aleppo University Hospital, Aleppo, Syria.

Aladdin Etr, Aleppo University Hospital, Aleppo, Syria.

Taoufik Ghazal Aswad, Aleppo University Hospital, Aleppo, Syria.

Hamdi Nawfal, Obstetrics and Gynecology - Embryology and Genetics Department- Aleppo University Faculty of Medicine, Aleppo, Syria.

Authors’ contributions

Leen Jarjanazi (project administration; supervision; writing—original draft; writing—review and editing), Sarah Kebbeh (Writing—original draft; review and editing), Eymar Alam (writing—original draft), Qamar Saado (writing—original draft), Mulham Jarjanazi (Revisions—Pediatric surgery resident), LAMA ALKADI (Pediatrician—the first examiner of the newborn), Aladdin Etr (Plastic surgeon—Follow-up the complaint of missing scalp), Taoufik Ghazal Aswad (Neurosurgeon—Neurosurgical consultation—Follow up dressings), Hamdi Nawfal (Supervisor—obstetrician).

Funding

There are no sources of funding.

Data availability

All data generated or analysed during this study are included in this published article and its supplementary information files.

Follow up

By the time we prepared this case report, the mother had become pregnant again. She discontinued all previous medications and received appropriate prenatal care, ultimately delivering a healthy baby boy.

Ethics approval and consent to participate

Not required for case reports at our hospital. Single case reports are exempt from ethical approval at our institution.

Consent for publication

The mother provided written informed consent for the publication of potentially identifying images and clinical details, on behalf of herself and the child.

Competing interests

The authors declare that they have no competing interests.

References

  • 1. Meester  JAN, Southgate  L, Stittrich  A-B. et al.  Heterozygous loss-of-function mutations in DLL4 cause Adams-Oliver syndrome. Am J Hum Genet  2015;97:475–82. 10.1016/j.ajhg.2015.07.015 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Suarez  E, Bertoli  MJ, Eloy  JD. et al.  Case report and review of literature of a rare congenital disorder: Adams-Oliver syndrome. BMC Anesthesiol  2021;21:117. 10.1186/s12871-021-01339-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Shiji Chalipat, Kiran CR, Mathew A, Mane S. Adams-Oliver Syndrome: Piecing Together the Puzzle of a Rare Condition. Medical Journal of Dr D Y Patil Vidyapeeth. 2025;18:526–528. 10.4103/mjdrdypu.mjdrdypu_1003_24 [DOI] [Google Scholar]
  • 4. Lehman  A, Wuyts  W, Patel  MS. Adams-Oliver Syndrome. In: GeneReviews® [Internet]. Adam  MP, Ardinger  HH, Pagon  RA. et al. eds. University of Washington, Seattle: Seattle (WA), 2016, 1993–2022. [Google Scholar]
  • 5. Pérez-García  C, Martín  YR, Del Hoyo  AA. et al.  Adams-Oliver syndrome with unusual central nervous system findings and an extrahepatic portosystemic shunt. Pediatr Rep  2017;9:7211. 10.4081/pr.2017.7211 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Amor  DJ, Leventer  RJ, Hayllar  S. et al.  Polymicrogyria associated with scalp and limb defects: variant of Adams-Oliver syndrome. Am J Med Genet  2000;93:328–34. [DOI] [PubMed] [Google Scholar]
  • 7. Savarirayan  R, Thompson  EM, Abbott  KJ. et al.  Cerebral cortical dysplasia and digital constriction rings in Adams-Oliver syndrome. Am J Med Genet  1999;86:15–9. [DOI] [PubMed] [Google Scholar]
  • 8. Tan  AP, Mankad  K. Adams Oliver syndrome with cerebellar cortical dysplasia. Childs Nerv Syst  2018;34:1109–10. 10.1007/s00381-018-3810-1 [DOI] [PubMed] [Google Scholar]
  • 9.Zhu, Victor Z. et al. “Adams-Oliver Syndrome: Vestigial Tail and Genetics Update.” Archives of Plastic Surgery 2022;49:517–522. 10.1055/s-0042-1751107 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Beekmans SJ, Wiebe MJ. “Surgical treatment of aplasia cutis in the Adams-Oliver syndrome.” The Journal of Craniofacial Surgery 2001;12:569–72. 10.1097/00001665-200111000-00014 [DOI] [PubMed] [Google Scholar]
  • 11. Srihari  S, Asha  GS. Adams-Oliver syndrome - a case report. Indian Dermatol Online J  2022;14:422–3. 10.4103/idoj.idoj_330_22 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Rashid  S, Azeem  S, Riaz  S. Adams-Oliver syndrome: a rare congenital disorder. Cureus.  2022;14:e23297. 10.7759/cureus.23297 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Dudoignon  B, Huber  C, Michot  C. et al.  Expanding the phenotype in Adams–Oliver syndrome correlating with the genotype. Am J Med Genet A  2020;182:29–37. 10.1002/ajmg.a.61364 [DOI] [PubMed] [Google Scholar]
  • 14.Iftikhar N. Ahmad Ghumman FI, Janjua SA, Ejaz A, Butt UA. Adams-Oliver syndrome. J Coll Physicians Surg Pak. 2014;24:76–7. [PubMed] [Google Scholar]
  • 15. Grigoriadis  S, VonderPorten  EH, Mamisashvili  L. et al.  Antidepressant exposure during pregnancy and congenital malformations: is there an association? A systematic review and meta-analysis of the best evidence. The Journal of clinical psychiatry  2013;74:e293–308. 10.4088/JCP.12r07966 [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

All data generated or analysed during this study are included in this published article and its supplementary information files.


Articles from Oxford Medical Case Reports are provided here courtesy of Oxford University Press

RESOURCES